Mark J. Levin, Director at MILLENNIUM PHARMACEUTICALS INC (MLNM), sold 10,000 shares at $15.70 ($156K) on 2007-12-26, disclosed to the SEC on 2007-12-27.
Scheduled sale ($156k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.33 | 200 | $3K | 2.0% |
| 2 | $15.34 | 100 | $2K | 1.0% |
| 3 | $15.35 | 200 | $3K | 2.0% |
| 4 | $15.40 | 100 | $2K | 1.0% |
| 5 | $15.44 | 100 | $2K | 1.0% |
| 6 | $15.46 | 100 |
| $2K |
| 1.0% |
| 7 | $15.47 | 200 | $3K | 2.0% |
| 8 | $15.48 | 100 | $2K | 1.0% |
| 9 | $15.49 | 1,400 | $22K | 13.9% |
| 10 | $15.50 | 1,800 | $28K | 17.9% |
| 11 | $15.51 | 800 | $12K | 8.0% |
| 12 | $15.52 | 500 | $8K | 5.0% |
| 13 | $15.53 | 100 | $2K | 1.0% |
| 14 | $15.55 | 100 | $2K | 1.0% |
| 15 | $15.59 | 100 | $2K | 1.0% |
| 16 | $15.65 | 600 | $9K | 6.0% |
| 17 | $15.66 | 900 | $14K | 9.0% |
| 18 | $15.67 | 100 | $2K | 1.0% |
| 19 | $15.70 | 700 | $11K | 7.1% |
| 20 | $15.71 | 100 | $2K | 1.0% |
| 21 | $15.72 | 100 | $2K | 1.0% |
| 22 | $15.73 | 200 | $3K | 2.0% |
| 23 | $15.75 | 900 | $14K | 9.1% |
| 24 | $15.76 | 200 | $3K | 2.0% |
| 25 | $15.78 | 100 | $2K | 1.0% |
| 26 | $15.80 | 200 | $3K | 2.0% |
| Total | $15.58 avg | 10,000 | $156K | 100% |
| Filing → |
| MLNM | SELL | 2008-01-10 | $29K | — | Filing → |
| MLNM | SELL | 2008-01-10 | $122K | — | Filing → |
| MLNM | SELL | 2008-01-03 | $120K | — | Filing → |